FDA Approves Baxalta's von Willebrand Disease Drug

Vonvendi is the first FDA-approved recombinant von Willebrand factor for the on-demand treatment and control of bleeding episodes
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news